Article
CEP72 Promotes Malignant Progression and Shapes the Tumor Immune Microenvironment in Hepatocellular Carcinoma: Integrated Multi-cohort Bioinformatics and In Vitro Validation
2026-03-20
Abstract excerpt
<title>Abstract</title> <p>Background Immune checkpoint inhibitors (ICIs) benefit only a subset of patients with hepatocellular carcinoma (HCC), and biomarkers linking ICI response with tumor biology remain limited. We investigated CEP72 as an ICI-response–associated gene and evaluated its prognostic, immune, and functional relevance in HCC. Methods Anti–PD-1 response–associated differentially expressed genes (...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 43f2b453-2fed-5070-b4c2-bb09cb36290f
- DOI
- 10.21203/rs.3.rs-9026891/v1
